Guggenheim Initiates Coverage On Zura Bio with Buy Rating, Announces Price Target of $20
Portfolio Pulse from richadhand@benzinga.com
Guggenheim analyst Yatin Suneja initiates coverage on Zura Bio (NASDAQ:ZURA) with a Buy rating and announces a price target of $20.
June 22, 2023 | 1:28 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Guggenheim analyst Yatin Suneja initiates coverage on Zura Bio with a Buy rating and a price target of $20.
The initiation of coverage by Guggenheim with a Buy rating and a price target of $20 indicates a positive outlook for Zura Bio's stock. This news is likely to attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100